The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
Open accessAbstract
Summary of statements: In Europe at present, but also in 2040, 1 in 3 cancer-related deaths are expected to be caused by digestive cancers. Endoscopic technologies enable diagnosis, with relatively low invasiveness, of precancerous conditions and early cancers, thereby improving patient survival. Overall, endoscopy capacity must be adjusted to facilitate both effective screening programs and rigorous control of the quality assurance and surveillance systems required. 1 For average-risk populations, ESGE recommends the implementation of organized population-based screening programs for colorectal cancer, based on fecal immunochemical testing (FIT), targeting individuals, irrespective of gender, aged between 50 and 75 years. Depending on local factors, namely the adherence of the target population and availability of endoscopy services, primary screening by colonoscopy or sigmoidoscopy may also be recommendable. 2 In high-risk populations, endoscopic screening for gastric cancer should be considered for individuals aged more than 40 years. Its use in countries/regions with intermediate risk may be considered on the basis of local settings and availability of endoscopic resources. 3 For esophageal and pancreatic cancer, endoscopic screening may be considered only in high-risk individuals: – For squamous cell carcinoma, in those with a personal history of head/neck cancer, achalasia, or previous caustic injury; – For Barrett’s esophagus (BE)-associated adenocarcinoma, in those with long-standing gastroesophageal reflux disease symptoms (i. e., > 5 years) and multiple risk factors (age ≥ 50 years, white race, male sex, obesity, first-degree relative with BE or esophageal adenocarcinoma [EAC]). – For pancreatic cancer screening, endoscopic ultrasound may be used in selected high-risk patients such as those with a strong family history and/or genetic susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784 · cited 12×
“The CAPS consortium recommends that all patients with Peutz–Jeghers syndrome and all carriers of germline CDKN2A mutation should be screened for pancreatic cancer regardless of family history starting at age 40.”
BackgroundMethodInfluentialFrequent detection of pancreatic lesions in asymptomatic high-risk individuals
Canto, M. I., Hruban, R. H., Fishman, E. K., Kamel, I. R., Schulick, R., Zhang, Z., Topazian, M., Takahashi, N., Fletcher, J., Petersen, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.01.005 · Cited by 648 · cited 1×
“The prospective CAPS3 study [104] performed blinded comparisons of CT, MRI/MRCP, and EUS for one-time screening.”
MethodCanto, M. I., Almario, J. A., Schulick, R. D., Yeo, C. J., Klein, A., Blackford, A., Shin, E. J., Sanyal, A., Yenokyan, G., Lennon, A. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.035 · Cited by 414 · cited 1×
“Recent data indicate that among individuals at high risk for pancreatic adenocarcinoma who were screened with EUS, MRI, and/or CT, most pancreatic cancers detected during surveillance (9/10) were resectable, and 85% of the patients survived for at least 3 years [116].”
BackgroundBrentnall, T. A., Bronner, M. P., Byrd, D. R., Haggitt, R. C., & Kimmey, M. B. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-4-199908170-00003 · Cited by 391
Verna, E. C., Hwang, C., Stevens, P. D., Rotterdam, H., Stavropoulos, S. N., Sy, C. D., Prince, M. A., Chung, W. K., Fine, R. L., Chabot, J. A., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3209 · Cited by 201
Harinck, F., Konings, I. C. A. W., Kluijt, I., Poley, J. W., van Hooft, J. E., van Dullemen, H. M., Nio, C. Y., Krak, N. C., Hermans, J. J., Aalfs, C. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308008 · Cited by 185 · cited 1×
“However, it has been shown that EUS was particularly sensitive for the early detection of small solid lesions, while MRI was very sensitive for the detection of (small) cystic lesions [107].”
BackgroundCorral, J. E., Mareth, K. F., Riegert-Johnson, D. L., Das, A., & Wallace, M. B. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.065 · Cited by 113
Lucas, A. L., Frado, L. E., Hwang, C., Kumar, S., Khanna, L. G., Levinson, E. J., Chabot, J. A., Chung, W. K., & Frucht, H. (2014) · Cancer · doi:10.1002/cncr.28662 · Cited by 68
The role of endoscopic ultrasound in pancreatic cancer screening
Bhutani, M., Koduru, P., Joshi, V., Saxena, P., Suzuki, R., Irisawa, A., & Yamao, K. (2016) · Endoscopic Ultrasound · doi:10.4103/2303-9027.175876 · Cited by 55 · cited 1×
“EUS has the ability to detect small pancreatic lesions, offers the possibility of tissue sampling, and is the most accepted screening method for early pancreatic cancer detection [85, 90, 91].”
Self-citation
Cited by
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Hassan, C., Antonelli, G., Dumonceau, J.-M., Regula, J., Bretthauer, M., Chaussade, S., Dekker, E., Ferlitsch, M., Gimeno-Garcia, A., Jover, R., et al. (2020) · Endoscopy · doi:10.1055/a-1185-3109 · Cited by 515
Self-citationArtificial Intelligence Allows Leaving-In-Situ Colorectal Polyps
Hassan, C., Balsamo, G., Lorenzetti, R., Zullo, A., & Antonelli, G. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.04.045 · Cited by 119
Self-citationvan Bokhorst, Q. N., Houwen, B. B., Hazewinkel, Y., Fockens, P., & Dekker, E. (2023) · Endoscopy International Open · doi:10.1055/a-2098-1999 · Cited by 8
Self-citation
Metadata
- Authors
- Săftoiu, A., Hassan, C., Areia, M., Bhutani, M. S., Bisschops, R., Bories, E., Cazacu, I. M., Dekker, E., Deprez, P. H., Pereira, S. P., Senore, C., Capocaccia, R., Antonelli, G., van Hooft, J., Messmann, H., Siersema, P. D., Dinis-Ribeiro, M., & Ponchon, T.
- Venue
- Endoscopy
- Publisher
- Georg Thieme Verlag KG
- Published
- 2020-02-12
- Volume
- 52
- Issue
- 04
- Pages
- 293-304
- ISSN
- 0013-726X (ISSN-L)
- 1438-8812
- OpenAlex
- W3006619456
- Cited by
- 192
- References
- 9
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. https://app.cochat.ai/papers/10.1055/a-1104-5245
- The paper
- Săftoiu, A., Hassan, C., Areia, M., Bhutani, M. S., Bisschops, R., Bories, E., Cazacu, I. M., Dekker, E., Deprez, P. H., Pereira, S. P., Senore, C., Capocaccia, R., Antonelli, G., van Hooft, J., Messmann, H., Siersema, P. D., Dinis-Ribeiro, M., & Ponchon, T. (2020). Role of gastrointestinal endoscopy in the screening of digestive tract cancers in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy. https://doi.org/10.1055/a-1104-5245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.